Fig. 2From: A blood-based composite panel that screens Alzheimer’s diseaseValidation of Individual plasma levels of four biomarkers in an independent cohort. A-D show levels of sLRP1, KLK4, GSN and Caspase 3. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page